Results 161 to 170 of about 8,130 (203)

Expanding Evidence of Leptomeningeal Involvement in MOGAD and Its Relevance to Its Pathophysiology. [PDF]

Neurol Neuroimmunol Neuroinflamm
Cacciaguerra L, Flanagan EP.
europepmc   +1 more source

Does a Polycistronic 2A Design Enable Functional FcRn Production for Antibody Pharmacokinetic Studies? [PDF]

Pharmaceutics
Nesmeyanova VS, Ushkalenko ND, Olkin SE, Kosenko MN, Rukhlova EA, Susloparov IM, Shcherbakov DN.   +6 more
europepmc   +1 more source

Obstetric Pharmacology at an Inflection Point. [PDF]

J Clin Pharmacol
Eke AC.
europepmc   +1 more source

Dulaglutide and pregnancy: a comprehensive safety assessment using the <i>ex vivo</i> placenta perfusion and <i>in vitro</i> models. [PDF]

Front Pharmacol
Kuoni S, Caviglia S, Dolder A, Gawinecka J, Ochsenbein-Kölble N, Simões-Wüst AP.   +5 more
europepmc   +1 more source

Case Report: Dual response to efgartigimod in myasthenia gravis and comorbid autoimmune disorders: a case series. [PDF]

Front Immunol
Li Y, Yang Y, Zhu Y, Zhu R.
europepmc   +1 more source

Nipocalimab-aahu in generalised myasthenia gravis: A new Fc receptor-targeted option for antibody-positive patients. [PDF]

Ibrain
Hussain JM, Ashfaq A, Shahid A, Mudassir F.   +3 more
europepmc   +1 more source

Universal broad-spectrum mucosal vaccine design for human coronaviruses inspired by artificial antibodies. [PDF]

NPJ Vaccines
Wu Y, Lu J, Fang L, Chen X, Zhao C, Zhang Z, Zhu X, Gao X, Li H, Yan Y, Shi J, Zhang J, Zhou P, Pan X.   +13 more
europepmc   +1 more source

Analytical Physicochemical and Functional Studies to Compare AryoTrust, a Follow-On Biologics, with the Originator Trastuzumab (Herceptin). [PDF]

Pharmaceutics
Al-Kinani KK, Alkufi HK, Taher SS.
europepmc   +1 more source